Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice

Pharmacology Biochemistry and Behavior

Volumn 75, Issue 2, 2003, Pages 335-340

  Li, Zhu ^a,c   Kim, Chan H ^b   Ichikawa, Junji ^a   Meltzer, Herbert Y ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c Psychiatric Hospital at Vanderbilt   (United States)

Author keywords

Eight arm radial maze; Phencyclidine (PCP); Schizophrenia; Working memory

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEPTH PERCEPTION; DRUG EFFECT; IMAGE PROCESSING; INJECTION; MALE; MAZE TEST; MEMORY; MOUSE; MOUSE STRAIN; NONHUMAN; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RAT; RAT STRAIN; SPECIES DIFFERENCE; STATISTICAL SIGNIFICANCE; TIME; TREATMENT WITHDRAWAL;

ANIMALIA; PRIMATES; RODENTIA;

EID: 0038107693     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00085-6     Document Type: Article

References (34)

1. Adams B., Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J. Neurosci. 18:1998;5545-5554.
2. Bontempi B., Grottick A.J., Lorea J., Babin N., Chalmers D., Menzaghi F. Cognitive performance in rats after withdrawal from chronic phencyclidine. Program No. 81.11.2002. Abstract viewer/itinerary planner. 2002;Society for Neuroscience, Washington, DC. On-line.
3. Corso T.D., Sesma M.A., Tenkova T.I., Der T.C., Wozniak D.F., Farber N.B.et al. Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res. 752:1997;1-14.
4. Cosgrove J., Newell T.G. Recovery of neuropsychological functions during reduction in use of phencyclidine. J. Clin. Psychol. 47:1991;159-169.
5. Deutsch J.A., Rogers J.B. Cholinergic excitability and memory: animal studies and their clinical implications. Davis K.L., Berger P.A. Brain acetylcholine and neuropsychiatric disease. 1979;175-204 Plenum, New York.
6. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23:1997;437-458.
7. Handelmann G.E., Contreras P.C., O'Donohue T.L. Selective memory impairment by phencyclidine in rats. Eur. J. Pharmacol. 140:1987;69-73.
8. Honig W.K. Studies on working memory in the pigeon. Hulse S.H., Fowler H., Hoing W.K. Cognitive processes in animal behavior. 1978;211-248 Erlbaum, Hillsdale, NJ.
9. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
10. Jentsch J.D., Redmond D.E., Elsworth J.D. Jr., Taylor J.R., Youngren K.D., Roth R.H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science. 277:1997;953-955.
11. Jentsch J.D., Tran A., Le D., Youngren K.D., Phil M., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rats. Neurosci. Lett. 258:1997;175-178.
12. Jentsch J.D., Dazzi L., Chhatwal J.P., Verrico C.D., Roth R.H. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. Neurosci. Lett. 258:1998;175-178.
13. Jentsch J.D., Roth R.H., Taylor J.R. Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity. Biol. Psychiatry. 48:2000;415-424.
14. Kenny J.T., Meltzer H.Y. Attention and higher cortical functions in schizophrenia. J. Neuropsychiatry Clin. Neurosci. 3:1991;269-275.
15. Kesner R.P., Dakis M. Phencyclidine disrupts acquisition and retention performance within a spatial continuous recognition memory task. Pharmacol. Biochem. Behav. 44:1993;419-424.
16. Kesner R.P., Dakis M. Phencyclidine injections into the dorsal hippocampus disrupt long- but not short-term memory within a spatial learning task. Psychopharmacology (Berl.). 120:1995;203-208.
17. Kesner R.P., Hardy J.D., Novak J.M. Phencyclidine and behavior: II. Active avoidance learning and radial arm maze performance. Pharmacol. Biochem. Behav. 18:1983;351-356.
18. Kesner R.P., Dakis M., Bolland B.L. Phencyclidine disrupts long- but not short-term memory within a spatial learning task. Psychopharmacology (Berl.). 111:1993;85-90.
19. Krystal J.H., Karper L.P., Siebyl J.P., Freeman G.K., Delaney R., Bremner J.D.et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry. 51:1994;199-214.
20. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 13:1995;9-19.
21. Lydon R.G., Nakajima S. Differential effects of scopolamine on working and reference memory depend upon level of training. Pharmacol. Biochem. Behav. 43:1992;645-650.
22. McCann D.J., Winter J.C. Effects of phencyclidine, N-allyl-N-normetazocine (SKF-10,047), and verapamil on performance in a radial maze. Pharmacol. Biochem. Behav. 24:1986;187-191.
23. Miyakawa T., Yamada M., Duttaroy A., Wess J. Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J. Neurosci. 21:2001;5239-5250.
24. Moretti R.J., Hassan S.Z., Goodman L.I., Meltzer H.Y. Comparison of ketamine and thiopental in healthy volunteers: effects on mental status, mood, and personality. Anesth. Analg. 63:1984;1087-1096.
25. Noda Y., Meltzer H.Y., Nabeshimal H.T., Ichikawa J. Clozapine, but not haloperidol, reverse phencyclidine (PCP)-induced impairment in an 8-arm radil maze performance in rats. Soc. Neurosci. Abstr. 2000;653.3.
26. Olney J.W., Labruyere J., Price M.T. Pathological changes in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
27. Olton D.S. Mazes, maps, and memory. Am. Psychol. 34:1979;583-596.
28. Olton D.S., Samuelson R.J. Remembrance of places passed: spatial memory in rats. J. Exp. Psychol. 2:1976;97-116.
29. Pehrson A.L., Wise S.D., Philibin S.D., Silver K.L., Porter J.H. The effects of subchronic PCP on 8-arm radial maze performance in mice. Program No. 494.8.2002. Abstract viewer/itinerary planner. 2002;Society for Neuroscience, Washington, DC. On-line.
30. Pontecorvo M.J., Clissold D.B., White M.F., Ferkany J.W. N-methyl-D-aspartate antagonists and working memory performance: comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosine. Behav. Neurosci. 105:1991;521-535.
31. Snyder S.H. Phencyclidine. Nature. 285:1980;355-356.
32. Stefani M.R., Moghaddam B. Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. Behav. Brain Res. 134:2002;267-274.
33. Sturgeon R.D., Fessler G.G., Meltzer H.Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotype behavior and ataxia in rats. Eur. J. Pharmacol. 59:1979;169-179.
34. Wozniak D.F., Brosnan-Watters G., Nardi A., McEwen M., Corso T.D., Olney J.W.et al. MK-801 neurotoxicity in male mice: histologic effects and chronic impairments in spatial learning. Brain Res. 707:1996;165-179.